Cargando…

Overcoming TRAIL Resistance for Glioblastoma Treatment

The tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) shows a promising therapeutic potential in cancer treatment as it exclusively causes apoptosis in a broad spectrum of cancer cells through triggering the extrinsic apoptosis pathway via binding to cognate death receptors, with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Longfei, Zhai, Xuan, Liang, Ping, Cui, Hongjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070820/ https://www.ncbi.nlm.nih.gov/pubmed/33919846 http://dx.doi.org/10.3390/biom11040572

Ejemplares similares

Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance
por: Zhou, Weihua, et al.
Publicado: (2019)

Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells
por: Zhu, Zhi-Chuan, et al.
Publicado: (2019)

Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy?
por: Deng, Longfei, et al.
Publicado: (2022)

Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
por: JIAPAER, Shabierjiang, et al.
Publicado: (2018)

Current approaches in enhancing TRAIL therapies in glioblastoma
por: Thang, Morrent, et al.
Publicado: (2023)

Targeting c-Met Receptor Overcomes TRAIL-Resistance in Brain Tumors
por: Du, Wanlu, et al.
Publicado: (2014)

Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
por: Wang, Chun, et al.
Publicado: (2023)

Barriers to overcoming immunotherapy resistance in glioblastoma
por: Gillette, Julia S., et al.
Publicado: (2023)

Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells
por: Rizzo, Andrea, et al.
Publicado: (2021)

Overcoming TRAIL-resistance by sensitizing prostate cancer 3D spheroids with taxanes
por: Grayson, Korie A., et al.
Publicado: (2021)

Overcoming Hypoxic-Resistance of Tumor Cells to TRAIL-Induced Apoptosis through Melatonin
por: Lee, You-Jin, et al.
Publicado: (2014)

Isolation of Various Flavonoids with TRAIL Resistance-Overcoming Activity from Blumea lacera
por: Manome, Teruhisa, et al.
Publicado: (2022)

Combination of long-acting TRAIL and tumor cell-targeted photodynamic therapy as a novel strategy to overcome chemotherapeutic multidrug resistance and TRAIL resistance of colorectal cancer
por: She, Tianshan, et al.
Publicado: (2021)

Caspase-8: A Novel Target to Overcome Resistance to Chemotherapy in Glioblastoma
por: Fianco, Giulia, et al.
Publicado: (2018)

Targeting the DNA Damage Response to Overcome Cancer Drug Resistance in Glioblastoma
por: Ferri, Alessandra, et al.
Publicado: (2020)

Combination of AAV-TRAIL with miR-221-Zip Therapeutic Strategy Overcomes the Resistance to TRAIL Induced Apoptosis in Liver Cancer
por: Ma, Sisi, et al.
Publicado: (2017)

Pyroptosis, ferroptosis, and autophagy cross-talk in glioblastoma opens up new avenues for glioblastoma treatment
por: Wan, Sicheng, et al.
Publicado: (2023)

The Emerging Roles of RNA Modifications in Glioblastoma
por: Dong, Zhen, et al.
Publicado: (2020)

Targeting the metabolic pathway of human colon cancer overcomes resistance to TRAIL-induced apoptosis
por: Carr, Ryan M, et al.
Publicado: (2016)

Stress-induced TRAILR2 expression overcomes TRAIL resistance in cancer cell spheroids
por: Stöhr, Daniela, et al.
Publicado: (2020)

Targeting Tumor Associated Macrophages to Overcome Conventional Treatment Resistance in Glioblastoma
por: Grégoire, Hélène, et al.
Publicado: (2020)

Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment
por: Miyazaki, Tsubasa, et al.
Publicado: (2020)

Advances in Immunotherapy for the Treatment of Adult Glioblastoma: Overcoming Chemical and Physical Barriers
por: Lechpammer, Mirna, et al.
Publicado: (2022)

Delivering Therapeutics to Glioblastoma: Overcoming Biological Constraints
por: Mathew, Elza N., et al.
Publicado: (2022)

Countering TRAIL Resistance in Melanoma
por: Eberle, Jürgen
Publicado: (2019)

The Recent Research Progress of NF-κB Signaling on the Proliferation, Migration, Invasion, Immune Escape and Drug Resistance of Glioblastoma
por: Shi, Pengfei, et al.
Publicado: (2023)

Overcoming drug resistance in glioblastoma: new options in sight?
por: Kopecka, Joanna, et al.
Publicado: (2021)

Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells
por: Trivedi, Rachana, et al.
Publicado: (2015)

Selenocysteine derivative overcomes TRAIL resistance in melanoma cells: evidence for ROS-dependent synergism and signaling crosstalk
por: Cao, Wenqiang, et al.
Publicado: (2014)

Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1
por: Lemke, J, et al.
Publicado: (2014)

Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin
por: Hartung, Franziska, et al.
Publicado: (2016)

Mechanical nanosurgery approach: assistance to overcome the chemotherapy resistance of glioblastoma
por: Chen, Qi, et al.
Publicado: (2023)

Nanotherapeutics Overcoming the Blood-Brain Barrier for Glioblastoma Treatment
por: Tang, Lin, et al.
Publicado: (2021)

The regulation of combined treatment-induced cell death with recombinant TRAIL and bortezomib through TRAIL signaling in TRAIL-resistant cells
por: Ryu, Sunhyo, et al.
Publicado: (2018)

Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma
por: Ramalho, Maria João, et al.
Publicado: (2022)

Low-Level Endothelial TRAIL-Receptor Expression Obstructs the CNS-Delivery of Angiopep-2 Functionalised TRAIL-Receptor Agonists for the Treatment of Glioblastoma
por: Krishna Moorthy, Nivetha, et al.
Publicado: (2021)

Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis
por: Tolksdorf, Beatrice, et al.
Publicado: (2021)

Curcumol Overcomes TRAIL Resistance of Non‐Small Cell Lung Cancer by Targeting NRH:Quinone Oxidoreductase 2 (NQO2)
por: Zhang, Jing, et al.
Publicado: (2020)

DDRE-24. TARGETING PURINE METABOLISM TO OVERCOME GLIOBLASTOMA THERAPY RESISTANCE
por: Zhou, Weihua, et al.
Publicado: (2021)

Inhibition of Carbonic Anhydrase 2 Overcomes Temozolomide Resistance in Glioblastoma Cells
por: Zhao, Kai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_th32sfuvddj3kjqqssf1jpdb0p